Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | GRM5 | P41594 | 2/20 | 0.40 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.40 |
| ▸ | AKR1C2 | P52895 | 2/20 | 0.40 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 3/20 | 0.39 |
| ▸ | HTT | P42858 | 3/20 | 0.39 |
| ▸ | HTR2B | P41595 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.37 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.37 |
| ▸ | BRD4 | O60885 | 1/20 | 0.37 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23927549 | 0.83 | KIF11 (0.41) | BRD4 | |
| SCHEMBL23444958 | 0.83 | KIF11 (0.41) | MEN1KMT2AHNF4A | |
| SCHEMBL28481448 | 0.83 | EGFR (0.42) | MAPTMEN1KMT2ARAB9AHNF4A | |
| SCHEMBL23371572 | 0.83 | CYP26A1 (0.44) | MEN1KMT2ACYP1A2CYP3A4CYP2C9 | |
| SCHEMBL23442477 | 0.82 | NPSR1 (0.47) | NPSR1GRM5AKR1C3AKR1C2MAPT | |
| SCHEMBL29760994 | 0.81 | GAA (0.37) | NPSR1MEN1KMT2AHNF4A | |
| SCHEMBL24561834 | 0.81 | GAA (0.37) | NPSR1MEN1KMT2AHNF4A | |
| SCHEMBL23927691 | 0.80 | RXRA (0.41) | MEN1KMT2A | |
| SCHEMBL23439405 | 0.79 | CYP26A1 (0.42) | MEN1KMT2ACYP1A2CYP3A4CYP2C9 | |
| SCHEMBL23421097 | 0.78 | CYP26A1 (0.38) | MEN1KMT2ACYP1A2CYP3A4CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230002420-A1 | ORGANIC LIGHT-EMITTING ELEMENT | LG CHEM, LTD. (KR) | 2023-01-05 | — | — | US | disclosed |
| US-20220399501-A1 | ORGANIC LIGHT-EMITTING ELEMENT | LG CHEM, LTD. (KR) | 2022-12-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230002420-A1 | ORGANIC LIGHT-EMITTING ELEMENT | CYBA, CRY1, CYP1A1 | NPSR1 3638/4885GRM5 4649/4885AKR1C3 831/4885 |
| US-20220399501-A1 | ORGANIC LIGHT-EMITTING ELEMENT | CYP1A1, AHR, CYP1B1 | NPSR1 3047/4885GRM5 4692/4885AKR1C3 554/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.